Resultats globals: 11 registres trobats en 0.01 segons.
Articles, 10 registres trobats
Documents de recerca, 1 registres trobats
Articles 10 registres trobats  
1.
5 p, 178.9 KB Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation : A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico / Orti, Guillermo (Grupo Español de Trasplante Hematopoyetico) ; Sanz, Jaime (Grupo Español de Trasplante Hematopoyetico) ; Bermudez, Arancha (Grupo Español de Trasplante Hematopoyetico) ; Caballero, Dolores (Grupo Español de Trasplante Hematopoyetico) ; Martinez, Carmen (Grupo Español de Trasplante Hematopoyetico) ; Malouf Sierra, Jorge 1971- (Institut d'Investigació Biomèdica Sant Pau) ; Cabrera Marin, José R. (Grupo Español de Trasplante Hematopoyetico) ; Espigado, Ildefonso (Grupo Español de Trasplante Hematopoyetico) ; Solano, Carlos (Grupo Español de Trasplante Hematopoyetico) ; Ferrà, Christelle (Grupo Español de Trasplante Hematopoyetico) ; García-Noblejas, Ana (Grupo Español de Trasplante Hematopoyetico) ; Jimenez, Santiago (Grupo Español de Trasplante Hematopoyetico) ; Sampol, Antonia (Grupo Español de Trasplante Hematopoyetico) ; Yañez, Lucrecia (Grupo Español de Trasplante Hematopoyetico) ; García-Gutiérrez, Valentin (Grupo Español de Trasplante Hematopoyetico) ; Pascual, Maria Jesus (Grupo Español de Trasplante Hematopoyetico) ; Jurado, Manuel (Grupo Español de Trasplante Hematopoyetico) ; Moraleda, José M. (Grupo Español de Trasplante Hematopoyetico) ; Valcarcel, David (Grupo Español de Trasplante Hematopoyetico) ; Sanz, Miguel A. (Grupo Español de Trasplante Hematopoyetico) ; Carreras, Enric (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Duarte, Rafael F. (Grupo Español de Trasplante Hematopoyetico) ; Universitat Autònoma de Barcelona
Allogeneic stem cell transplantation (allo-HCT) represents the most effective immunotherapy for acute myeloid leukemia (AML) and myeloid malignancies. However, disease relapse remains the most common cause of treatment failure. [...]
2016 - 10.1016/j.bbmt.2015.11.012
Biology of Blood and Marrow Transplantation, Vol. 22 Núm. 3 (january 2016) , p. 584-588  
2.
15 p, 694.5 KB Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms : results from the EPICOVIDEHA registry / Marchetti, Monia (Azienda Ospedaliera Nazionale) ; Salmanton-García, Jon (University of Cologne, Cologne, Germany) ; El-Ashwah, Shaimaa (Mansoura University. Oncology Center) ; Verga, Luisa (Università Milano-Bicocca) ; Itri, Federico (San Luigi Gonzaga Hospital-Orbassano, Orbassano, Italy) ; Ráčil, Zdeněk (Institute of Hematology and Blood Transfusion, Prague, Czech Republic) ; Dávila-Valls, Julio (Hospital Nuestra Señora de Sonsoles (Àvila)) ; Martín-Pérez, Sonia (Hospital Nuestra Señora de Sonsoles (Àvila)) ; Van Doesum, Jaap (University Medical Center Groningen, The Netherlands) ; Passamonti, Francesco (University Insubria, Varese, Italy) ; Abu-Zeinah, Ghaith (Division of Hematology and Oncology, Weill Cornell Medicine, New York) ; Farina, Francesca (IRCCS Ospedale San Raffaele, Milan, Italy) ; López-García, Alberto (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Dragonetti, Giulia (Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Rome) ; Cattaneo, Chiara (Hematology Unit, ASST-Spedali Civili, Brescia, Italy) ; Gomes Da Silva, Maria (Portuguese Institute of Oncology, Lisbon, Portugal) ; Bilgin, Yavuz M. (Department of Internal Medicine, ADRZ, Goes, The Netherlands) ; Žák, Pavel (University Hospital Hradec Kralove (República Txeca)) ; Petzer, Verena (Medical University of Innsbruck, Austria) ; Glenthøj, Andreas (Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark) ; Espigado, Ildefonso (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ; Buquicchio, Caterina (Ospedale Dimiccoli Barletta, Italy) ; Bonuomo, Valentina (University of Verona, Italy) ; Prezioso, Lucia (Hospital University of Parma, Italy) ; Meers, Stef (AZ KLINA, Brasschaat, Belgium) ; Duarte, Rafael (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Bergantim, Rui ; Jakšić, Ozren ; Čolović, Natasha ; Blennow, Ola ; Cernan, Martin ; Schönlein, Martin ; Samarkos, Michail ; Mitra, Maria Enza ; Magliano, Gabriele ; Maertens, Johan ; Ledoux, Marie-Pierre ; Jiménez, Moraima (Hospital Universitari Vall d'Hebron) ; Demirkan, Fatih ; Collins, Graham ; Cabirta, Alba (Hospital Universitari Vall d'Hebron) ; Gräfe, Stefanie K. ; Nordlander, Anna ; Wolf, Dominik ; Arellano, Elena ; Cordoba, Raul ; Hanakova, Michaela ; Zambrotta, Giovanni ; Nunes Rodrigues, Raquel ; Limberti, Giulia ; Marchesi, Francesco ; Cornely, Oliver A. ; Pagano, Livio ; Universitat Autònoma de Barcelona
Patients with Philadelphia-negative chronic myeloproliferative neoplasms (MPN) typically incur high rates of infections and both drugs and comorbidities may modulate infection risk. The present study aims to assess the effect of immunosuppressive agents on clinical outcomes of MPN patients affected by the coronavirus disease 2019 (COVID-19). [...]
2023 - 10.1177/20406207231154706
Therapeutic Advances in Hematology, Vol. 14 (march 2023)  
3.
13 p, 3.3 MB Results of haploidentical transplant in patients with donor-specific antibodies : a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy / Bailén, Rebeca (Hospital General Universitario Gregorio Marañón) ; Alenda, Raquel (Centro de Transfusión de la Comunidad de Madrid) ; Herruzo-Delgado, Beatriz (Hospital Regional Universitario de Málaga) ; Acosta-Fleitas, Cynthia (Hospital Universitario de Gran Canaria Dr. Negrín) ; Vallés, Ana (Hospital Universitario Ramón y Cajal (Madrid)) ; Esquirol, Albert (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Fonseca, Marta (Hospital Clínico Universitario (Salamanca)) ; Solán, Laura (Hospital Universitario Fundación Jiménez Díaz) ; Sánchez-Vadillo, Irene (Hospital Universitario La Paz (Madrid)) ; Bautista, Guiomar (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Bento, Leyre (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; López-Godino, Oriana (Hospital Universitario Morales Meseguer) ; Pérez-Martínez, Ariadna (Hospital Clínic Universitari (València)) ; Torrent Catarineu, Anna (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Zanabili, Joud (Hospital Universitario Central de Asturias) ; Calbacho, Maria (Hospital Universitario 12 de Octubre (Madrid)) ; Moreno, Miguel Ángel (Centro de Transfusión de la Comunidad de Madrid) ; Pascual-Cascón, María Jesús (Hospital Regional Universitario de Málaga) ; Guerra-Domínguez, Luisa (Hospital Universitario de Gran Canaria Dr. Negrín) ; Chinea, Anabelle (Hospital Universitario Ramón y Cajal (Madrid)) ; Garcia Cadenas, Irene (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; López-Corral, Lucía (Hospital Clínico Universitario (Salamanca)) ; Boix, Francisco (Universidad de Salamanca) ; López Lorenzo, José Luis (Hospital Universitario Fundación Jiménez Díaz) ; Humala, Karem (Hospital Universitario La Paz (Madrid)) ; Duarte, Rafael (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Sampol, Antonia (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Heras, Inmaculada (Hospital Universitario Morales Meseguer) ; Vicario, José Luis (Centro de Transfusión de la Comunidad de Madrid) ; Balas, Antonio (Centro de Transfusión de la Comunidad de Madrid) ; Oarbeascoa, Gillen (Hospital General Universitario Gregorio Marañón) ; Fernández-Caldas, Paula (Hospital General Universitario Gregorio Marañón) ; Anguita, Javier (Universidad Complutense de Madrid) ; Kwon, Mi (Universidad Complutense de Madrid) ; Universitat Autònoma de Barcelona
Donor-specific antibodies (DSAs) are IgG allo-antibodies against mismatched donor HLA molecules and can cause graft failure (GF) in the setting of haploidentical hematopoietic stem cell transplantation (haplo-HSCT). [...]
2023 - 10.3389/fimmu.2023.1165759
Frontiers in immunology, Vol. 14 (may 2023)  
4.
8 p, 1.8 MB Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT) : an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE) / Saccardi, Riccardo (Careggi University Hospital (Florència, Itàlia)) ; Putter, Hein (Leiden University Medical Center) ; Eikema, Dirk-Jan (EBMT Statistical Unit Leiden) ; Busto, María Paula (EBMT Registry) ; McGrath, Eoin (ICCBBA (Barcelona, Espanya)) ; Middelkoop, Bas (European Society for Blood and Marrow Transplantation-EBMT Registry) ; Adams, Gillian (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ; Atlija, Marina (European Society for Blood and Marrow Transplantation-EBMT Registry) ; Ayuk, Francis Ayuketang (University Medical Center Hamburg) ; Baldomero, Helen (University Hospital Basel (Basilea, Suïssa)) ; Beguin, Yves (CHU of Liège and University of Liège) ; de la Camara, Rafael (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ; Cedillo Cedillo, Angel (Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular) ; Balari, Anna María Sureda (Hospital Universitari de Bellvitge) ; Chabannon, Christian (Institut Paoli-Calmettes Comprehensive Cancer Centre) ; Corbacioglu, Selim (University Children's Hospital Regensburg) ; Dolstra, Harry (Radboud University Medical Center) ; Duarte, Rafael (Universidad Autónoma de Madrid) ; Duléry, Rémy (Sorbonne Université) ; Greco, Raffaella (Autoimmune Diseases Working Party (Barcelona, Espanya)) ; Gusi, Andreu (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ; Hamad, Nada (University of Notre Dame Australia) ; Kenyon, Michelle (King's College Hospital NHS Foundation Trust) ; Kroeger, Nicolaus (University Medical Center Hamburg) ; Labopin, Myriam (European Society for Blood and Marrow Transplantation-EBMT Paris Study Office) ; Lee, Julia (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ; Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Manson, Lynn (Edinburgh & SE Scotland Clinical Transfusion Centre Patient Services (Regne Unit)) ; Mensil, Florence (Agence de la Biomédecine) ; Milpied, Noel (Centre Hospitalier Universitaire Bordeaux) ; Mohty, Mohamad (Sorbonne University) ; Oldani, Elena (Italian National BMT Registry) ; Orchard, Kim (University Hospital Southampton NHS) ; Passweg, Jakob (University Hospital Basel (Basilea, Suïssa)) ; Pearce, Rachel (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ; de Latour, Régis Peffault (BMT unit Paris Cité University) ; Poirel, Hélène A. (Belgian Transplant Registry) ; Rintala, Tuula (King's College Hospital NHS Foundation Trust) ; Rizzo, J. Douglas (CIBMTR, Medical College of Wisconsin) ; Ruggeri, Annalisa (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Sanchez-Martinez, Carla (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ; Sanchez-Guijo, Fermin (CIC-University of Salamanca) ; Sánchez-Ortega, Isabel (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ; Trnková, Marie (Czech registry Czech Republic) ; Valcárcel, David (Vall d'Hebron Institut d'Oncologia) ; Wilcox, Leonie (Australasian Bone Marrow Transplant Recipient Registry) ; de Wreede, Liesbeth C. (Leiden University Medical Center) ; Snowden, John A. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ; Universitat Autònoma de Barcelona
From 2016 EBMT and JACIE developed an international risk-adapted benchmarking program of haematopoietic stem cell transplant (HSCT) outcome to provide individual EBMT Centers with a means of quality-assuring the HSCT process and meeting FACT-JACIE accreditation requirements relating to 1-year survival outcomes. [...]
2023 - 10.1038/s41409-023-01924-6
Bone marrow transplantation, march 2023, p. 1-8  
5.
9 p, 1.5 MB Outcome of COVID-19 in allogeneic stem cell transplant recipients : Results from the EPICOVIDEHA registry / Busca, Alessandro (AOU Citta' della Salute e della Scienza) ; Salmanton-García, Jon (University of Cologne) ; Marchesi, Francesco (IRCCS Regina Elena National Cancer Institute) ; Farina, Francesca (IRCCS Ospedale San Raffaele) ; Seval, Guldane Cengiz (Ankara University) ; Van Doesum, Jaap (University Medical Center Groningen) ; De Jonge, Nick (Amsterdam UMC) ; Bahr, Nathan C. (University of Kansas Medical Center) ; Maertens, Johan (K.U. Leuven and Department of Hematology) ; Meletiadis, Joseph ("Attikon" University General Hospital) ; Fracchiolla, Nicola (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ; Weinbergerová, Barbora (Department of Internal Medicine - Hematology and Oncology, Masaryk University Hospital Brno) ; Verga, Luisa (Università Milano-Bicocca) ; Ráčil, Zdeněk (Institute of Hematology and Blood Transfusion) ; Jiménez, Moraima (Universitat Autònoma de Barcelona. Departament de Medicina) ; Glenthøj, Andreas (Copenhagen University Hospital) ; Blennow, Ola (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Tanase, Alina Daniela (University of Medicine and Pharmacy Carol Davila) ; Schönlein, Martin (University Medical Center Hamburg-Eppendorf. Department of Oncology, Hematology and Bone Marrow Transplantation) ; Prezioso, Lucia (Hospital University of Parma - Hematology and Bone Marrow Unit) ; Khanna, Nina (University Hospital Basel (Basilea, Suïssa)) ; Duarte, Rafael (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Žák, Pavel (University Hospital Hradec Kralove (República Txeca)) ; Nucci, Marcio (Federal University of Rio de Janeiro) ; Machado, Marina (Hospital General Universitario Gregorio Marañón) ; Kulasekararaj, Austin (King's College London) ; Espigado, Ildefonso (Instituto de Biomedicina de Sevilla) ; De Kort, Elizabeth (Radboudumc) ; Ribera-Santa Susana, José-María (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Marchetti, Monia (Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo) ; Magliano, Gabriele (ASST Grande Ospedale Metropolitano Niguarda) ; Falces-Romero, Iker (Hospital Universitario La Paz (Madrid)) ; Ilhan, Osman (Ankara University) ; Ammatuna, Emanuele (University Medical Center Groningen) ; Zompi, Sofia (Stem Cell Transplant Center, AOU Citta' della Salute e della Scienza) ; Tsirigotis, Panagiotis (National and Kapodistrian University of Athens. "Attikon" University General Hospital) ; Antoniadou, Anastasia (National and Kapodistrian University of Athens. "Attikon" University General Hospital) ; Zambrotta, Giovanni (Università Milano-Bicocca) ; Nordlander, Anna (Department of Infectious Diseases, Karolinska University Hospital) ; Karlsson, Linda Katharina (University of Copenhagen) ; Hanakova, Michaela (Institute of Hematology and Blood Transfusion) ; Dragonetti, Giulia (Fondazione Policlinico Universitario Agostino Gemelli - IRCCS) ; Cabirta, Alba (Vall d'Hebron Institut d'Oncologia) ; Berg Venemyr, Caroline (Copenhagen University Hospital - Rigshospitalet) ; Gräfe, Stefanie (University of Cologne) ; Van Praet, Jens (AZ Sint-Jan Brugge-Oostende AV. Department of Nephrology and Infectious diseases) ; Tragiannidis, Athanasios (Aristotle University of Thessaloniki) ; Petzer, Verena (Medical University of Innsbruck. Department of Hematology and Oncology) ; López-García, Alberto (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (Madrid)) ; Itri, Federico (San Luigi Gonzaga Hospital - Orbassano) ; Groh, Ana (Infektiologie, Universitätsklinikum Frankfurt am Main) ; Gavriilaki, Eleni (General Hospital of Thessaloniki "George Papanikolaou") ; Dargenio, Michelina (Hematology and Stem Cell Transplant Unit) ; Rahimli, Laman (University of Cologne) ; Cornely, Oliver A. (German Centre for Infection Research (DZIF)) ; Pagano, Livio (Università Cattolica del Sacro Cuore)
The outcome of COVID-19 in allogeneic hematopoietic stem cell transplantation (HSCT) recipients is almost uniformely considered poor. The aim of present study was to retrospectively analyse the outcome and risk factors for mortality in a large series of patients who developed COVID-19 infection after an allogeneic HSCT. [...]
2023 - 10.3389/fimmu.2023.1125030
Frontiers in immunology, Vol. 14 (february 2023)  
6.
15 p, 1.8 MB COVID-19 infection in adult patients with hematological malignancies : a European Hematology Association Survey (EPICOVIDEHA) / Pagano, Livio (Università Cattolica del Sacro Cuore) ; Salmanton-García, Jon (University of Cologne) ; Marchesi, Francesco (IRCCS Regina Elena National Cancer Institute) ; Busca, Alessandro (AOU Citta' Della Salute E Della Scienza) ; Corradini, Paolo (University of Milan) ; Hoenigl, Martin (Medical University of Graz) ; Klimko, Nikolai (North-Western State Medical University Named After Iliá Ilich Méchnikov (Sant Petersburg, Rússia)) ; Koehler, Philipp (University of Cologne. Faculty of Medicine) ; Pagliuca, Antonio (King's College Hospital NHS Foundation Trust) ; Passamonti, Francesco (University of Insubria) ; Verga, Luisa (Università Milano-Bicocca) ; Víšek, Benjamin (University Hospital Hradec Kralove (República Txeca)) ; Ilhan, Osman (Ankara University) ; Nadali, Gianpaolo (Policlinico Borgo Roma Verona (Verona, Itàlia)) ; Weinbergerová, Barbora (University Hospital Brno (República Txeca)) ; Cordoba, Raul (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Marchetti, Monia (Azienda Ospedaliera Nazionale SS. Antonio E Biagio E Cesare Arrigo) ; Collins, Graham (NIHR Oxford Biomedical Research Centre) ; Farina, Francesca (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Cattaneo, Chiara (ASST-Spedali Civili) ; Cabirta, Alba (Hospital Universitari Vall d'Hebron) ; Gomes da Silva, Maria (Portuguese Institute of Oncology) ; Itri, Federico (San Luigi Gonzaga Hospital - Orbassano) ; van Doesum, Jaap A (University Medical Center Groningen) ; Ledoux, Marie-Pierre (ICANS) ; Čerňan, Martin (University Hospital Olomouc (Olomouc, República Txeca)) ; Jakšić, Ozren (University Hospital Dubrava) ; Duarte, Rafael (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Magliano, Gabriele (ASST Grande Ospedale Metropolitano Niguarda (Milà, Itàlia)) ; Omrani, Ali S. (Communicable Disease Center, Hamad Medical Corporation) ; Fracchiolla, Nicola (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ; Kulasekararaj, Austin (King's College London) ; Valković, Toni (University of Rijeka. Faculty of Medicine) ; Poulsen, Christian Bjørn (Zealand University Hospital) ; Machado, Marina (Hospital General Universitario Gregorio Marañón) ; Glenthøj, Andreas (University of Copenhagen) ; Stoma, Igor (Gomel State Medical University) ; Ráčil, Zdeněk (Institute of Hematology and Blood Transfusion) ; Piukovics, Klára (University of Szeged. Department of Internal Medicine) ; Navrátil, Milan (University Hospital Ostrava) ; Emarah, Ziad (Mansoura University. Oncology Center) ; Sili, Uluhan (Marmara University) ; Maertens, Johan (KU Leuven) ; Blennow, Ola (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Bergantim, Rui (University of Porto) ; Garcia-Vidal, Carolina (Hospital Clínic i Provincial de Barcelona) ; Prezioso, Lucia (U.O. Ematologia E Centro Trapianti Midollo Osseo, Ospedale Maggiore) ; Guidetti, Anna (Fondazione IRCCS Istituto Nazionale Dei Tumori) ; del Principe, Maria Ilaria (University of Rome Tor Vergata. Department of Biomedicine and Prevention) ; Popova, Marina (Pavlov University) ; De Jonge, Nick (Amsterdam UMC, Location VUmc) ; Ormazabal-Vélez, Irati (Complejo Hospitalario de Navarra) ; Fernández, Noemí (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Falces-Romero, Iker (Hospital Universitario La Paz (Madrid)) ; Cuccaro, Annarosa (Azienda USL Toscana NordOvest (Livorno, Itàlia)) ; Meers, Stef (AZ Klina) ; Buquicchio, Caterina (Ematologia Con Trapianto, Ospedale Dimiccoli Barletta, Barletta, Italy) ; Antić, Darko (University of Belgrade. Faculty of Medicine) ; Al-Khabori, Murtadha (Sultan Qaboos University Hospital) ; García-Sanz, Ramón (IBSAL, Centro de Investigación del Cáncer-IBMCC) ; Biernat, Monika M. (Wroclaw Medical University) ; Tisi, Maria Chiara (San Bortolo Hospital. Cell Therapy and Hematology) ; Sal, Ertan (University of Cologne, Faculty of Medicine and University Hospital Cologne. Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases) ; Rahimli, Laman (University of Cologne. Faculty of Medicine) ; Čolović, Natasa (University of Belgrade. Faculty of Medicine) ; Schönlein, Martin (University Medical Center Hamburg-Eppendorf. Department of Oncology, Hematology and Bone Marrow Transplantation With Section of Pneumology) ; Calbacho, Maria (Hospital Universitario 12 de Octubre (Madrid)) ; Tascini, Carlo (Azienda Sanitaria Universitaria del Friuli Centrale (Udine, Itàlia)) ; Miranda-Castillo, Carolina (Hospital Universitario Rey Juan Carlos (Madrid)) ; Khanna, Nina (University Hospital Basel (Basilea, Suïssa)) ; Méndez, Gustavo-Adolfo (Hospital Escuela de Agudos Dr. Ramón Madariaga, Posadas, Argentina) ; Petzer, Verena (Medical University of Innsbruck. Department of Hematology and Oncology) ; Novák, Jan (University Hospital of Královské Vinohrady) ; Besson, Caroline (Centre Hospitalier de Versailles) ; Duléry, Rémy (Sorbonne Université) ; Lamure, Sylvain (Universite de Montpellier. Departement d'Hematologie Clinique) ; Nucci, Marcio (Federal University of Rio de Janeiro) ; Zambrotta, Giovanni (Università Milano-Bicocca) ; Žák, Pavel (University Hospital Hradec Kralove (República Txeca)) ; Seval, Guldane Cengiz (Ankara University) ; Bonuomo, Valentina (Policlinico Borgo Roma Verona, Verona, Italy) ; Mayer, Jiří (University Hospital Brno (República Txeca)) ; López-García, Alberto (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Sacchi, Maria Vittoria (Azienda Ospedaliera Nazionale SS. Antonio E Biagio E Cesare Arrigo. Hematology and BMT Unit) ; Booth, Stephen (NIHR Oxford Biomedical Research Centre, Churchill Hospital) ; Ciceri, Fabio (IRCCS San Raffaele Scientific Institute. Hematology and Bone Marrow Transplantation) ; Oberti, Margherita (ASST-Spedali Civili) ; Salvini, Marco (University of Insubria) ; Izuzquiza, Macarena (Universitat Autònoma de Barcelona. Departament de Medicina) ; Nunes-Rodrigues, Raquel (Portuguese Institute of Oncology) ; Ammatuna, Emanuele (University Medical Center Groningen) ; Obr, Aleš (Palacky University. University Hospital Olomouc) ; Herbrecht, Raoul (ICANS) ; Núñez-Martín-Buitrago, Lucía (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Mancini, Valentina (ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy) ; Shwaylia, Hawraa (National Center for Cancer Care and Research, Hamad Medical Corporation) ; Sciumè, Mariarita (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ; Essame, Jenna (King's College Hospital NHS Foundation Trust) ; Nygaard, Marietta (Zealand University Hospital) ; Batinić, Josip (University of Zagreb. Faculty of Medicine) ; Gonzaga, Yung (Instituto Nacional Do Cancer. Hematology Service) ; Regalado-Artamendi, Isabel (Hospital General Universitario Gregorio Marañón) ; Karlsson, Linda Katharina (University of Copenhagen) ; Shapetska, Maryia (Scientific and Practical Center for Surgery, Transplantology and Hematology (Mins, Bielorússia)) ; Hanakova, Michaela (Institute of Hematology and Blood Transfusion) ; El-Ashwah, Shaimaa (Mansoura University. Oncology Center) ; Borbényi, Zita (University of Szeged. Department of Internal Medicine) ; Çolak, Gökçe Melis (Marmara University) ; Nordlander, Anna (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Dragonetti, Giulia (Università Cattolica del Sacro Cuore) ; Maraglino, Alessio Maria Edoardo (Università Cattolica del Sacro Cuore) ; Rinaldi, Amelia (U.O. Ematologia E Centro Trapianti Midollo Osseo, Ospedale Maggiore) ; De Ramón-Sánchez, Cristina (Instituto de Investigación Biomédica de Salamanca) ; Cornely, Oliver A. (German Centre for Infection Research (DZIF))
Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse outcomes may improve clinical management in these patients. [...]
2021 - 10.1186/s13045-021-01177-0
Journal of hematology & oncology, Vol. 14 (october 2021)  
7.
11 p, 572.5 KB Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients : a position statement from an international expert group / Mohty, Mohamad (Hematology Department. AP-HP. Hôpital Saint-Antoine. Sorbonne Université) ; Malard, F. (Hematology Department. AP-HP. Hôpital Saint-Antoine. Sorbonne Université) ; Abecasis, Manuel (Instituto Portugues de Oncologia) ; Aerts, E. (University Hospital Zurich (Suïssa)) ; Alaskar, A. S. (Department of Oncology. King Abdulaziz Medical City. King Abdullah International Medical Research Center. King Saud Bin Abdulaziz University for Health Sciences. Ministry of National Guard Health Affairs) ; Aljurf, Mahmoud (King Faisal Specialist Hospital and Research Centre) ; Arat, M. (HSCT Unit. Sisli Florence Nightingale Hospital) ; Bader, Peter (Division for Stem Cell Transplantation and Immunology. Department for Children and Adolescents. University Hospital. Goethe University) ; Baron, Frederic (CHU and University of Liege) ; Basak, G. (Medical University of Warsaw) ; Bazarbachi, A. (American University of Beirut. Department of Internal Medicine) ; Blaise, Didier (Transplant and Cellular Immunotherapy Program. Department of Hematology. Aix-Marseille Univ. Inserm. CNRS. Institut Paoli-Calmettes. CRCM) ; Ciceri, Fabio (Hematology and Bone Marrow Transplantation Unit. IRCCS Ospedale San Raffaele. University Vita-Salute) ; Corbacioglu, Selim (Department of Pediatric Hematology. Oncology and Stem Cell Transplantation. University of Regensburg) ; Dalle, J. H. (Department of Hematology and Immunology. Hospital Robert Debre. Paris 7-Paris Diderot University) ; Dignan, F. (Department of Clinical Haematology. Central Manchester Foundation Trust) ; Fukuda, T. (HSCT Division. National Cancer Center Hospital) ; Huynh, A. (Institut Universitaire du Cancer Toulouse-Oncopole) ; Kuball, J. (Department of Haematology. University Medical Centre) ; Lachance, S. (Department of Hematology and Stem Cell Transplant Program. Hôpital Maisonneuve-Rosemont. University of Montreal) ; Lazarus, H. (Case Western Reserve University) ; Masszi, T. (St László Hospital (Hongria)) ; Michallet, M. (Hematology Department. Groupement Hospitalier Sud. Hospices Civils de Lyon. Université Claude Bernard Lyon EST) ; Nagler, Arnon (Hematology and Bone Marrow Transplantation. Chaim Sheba Medical Center) ; NiChonghaile, M. (Trinity College Dublin) ; Okamoto, S. (Division of Hematology. Department of Medicine. Keio University School of Medicine) ; Pagliuca, A. (King's College Hospital NHS Foundation Trust) ; Peters, C. (Department of Pediatrics. St. Anna Kinderspital) ; Petersen, F. B. (LDS Hospital) ; Richardson, Paul G.. (Division of Hematology. Mayo Clinic) ; Ruutu, T. (Helsinki University Hospital (Finlàndia)) ; Saber, Wael (Center for International Blood and Marrow Transplant Research. Medical College of Wisconsin) ; Savani, B. N. (Hematology and Stem Cell Transplantation Section. Division of Hematology/Oncology. Department of Medicine. Vanderbilt University Medical Center and Veterans Affairs Medical Center) ; Soiffer, R. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Division of Hematologic Malignancies) ; Styczynski, Jan (Pediatric Hematology and Oncology. University Hospital. Collegium Medicum UMK) ; Wallhult, E. (Sahlgrenska University Hospital (Suècia)) ; Yakoub-Agha, Ibrahim (CHU de Lille. LIRIC INSERM U995. Université de Lille2) ; Duarte, Rafael (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Carreras, Enric (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
2020 - 10.1038/s41409-019-0705-z
Bone marrow transplantation, Vol. 55 Núm. 3 (january 2020) , p. 485-495  
8.
4 p, 794.2 KB Biosimilar and interchangeable : inseparable scientific concepts? / Mora Pérez, Fernando de (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Balsa, Alejandro ; Cornide-Santos, María (Hospital General de Segovia) ; Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Marsal, Sara (Hospital Universitari Vall d'Hebron) ; P. Gisbert, Javier (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Abad, Miguel-Angel (Hospital Virgen del Puerto) ; Duarte, Rafael (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Wiechmann, Michael ; Martínez Cabeza de Vaca, Rafael (Sandoz Iberia) ; Universitat Autònoma de Barcelona
2019 - 10.1111/bcp.14089
British Journal of Clinical Pharmacology, Vol. 85 (september 2019) , p. 2460-2463  
9.
8 p, 501.2 KB Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/ Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation / Sureda, Anna (Institut d'Investigació Biomèdica Sant Pau) ; Canals, Carme (European Society for Blood and Marrow Transplantation (Barcelona)) ; Arranz, Reyes (Hospital Universitario de la Princesa (Madrid)) ; Caballero, Dolores (Hospital Clínico Universitario (Salamanca)) ; Ribera, Jose-Maria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Brune, Mats (Sahlgrenska University Hospital (Suècia)) ; Passweg, Jacob (Hopitaux Universitaires de Geneve. Departement Medecine Interne) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Valcárcel, David (Institut d'Investigació Biomèdica Sant Pau) ; Besalduch, Joan (Hospital Universitari Son Dureta (Palma de Mallorca, Balears)) ; Duarte, Rafael (Institut Català d'Oncologia) ; León, Angel (Hospital Universitario de Jerez (Jerez de la Frontera)) ; Pascual, Maria Jesús (Hospital Regional Universitario Carlos Haya (Málaga)) ; García-Noblejas, Ana (Hospital Universitario de la Princesa (Madrid)) ; López Corral, Lucia (Hospital Clínico Universitario (Salamanca)) ; Xicoy, Blanca (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Sierra Gil, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Schmitz, Norbert (Asklepios Klinik St. Georg. Hematology/Oncology Department) ; Universitat Autònoma de Barcelona
Background: Although Hodgkin's lymphoma is a highly curable disease with modern chemotherapy protocols, some patients are primary refractory or relapse after first-line chemotherapy or even after high-dose therapy and autologous stem cell transplantation. [...]
2012 - 10.3324/haematol.2011.045757
Haematologica, Vol. 97, Núm. 2 (january 2012) , p. 310-317  
10.
15 p, 1.7 MB The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature / Díaz-Beyá, Marina (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Brunet Mauri, Maria Salut (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Nomdedeu, Josep (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Pratcorona, Marta (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Cordeiro, Anna (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Gallardo, David (Institut Català d'Oncologia) ; Escoda, Lourdes (Hospital Universitari Joan XXIII de Tarragona) ; Tormo, Mar (Hospital Clínic Universitari (València)) ; Heras, Inmaculada (Hospital General Universitario Morales Meseguer (Múrcia)) ; Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Duarte, Rafael (Institut Català d'Oncologia) ; Llano Queipo, María Paz de (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Bargay, Joan (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ; Sampol, Antonia (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Nomdedeu, Meritxell (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Risueño, Ruth M. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Hoyos Colell, Montserrat (Institut d'Investigació Biomèdica Sant Pau) ; Sierra Gil, Jorge (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Monzo, Mariano (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Navarro, Alfons (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Esteve Reyner, Jordi (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Cooperative AML group CETLAM ; Universitat Autònoma de Barcelona
Long non-coding RNAs (lncRNAs) are deregulated in several tumors, although their role in acute myeloid leukemia (AML) is mostly unknown. We have examined the expression of the lncRNA HOX antisense intergenic RNA myeloid 1 (HOTAIRM1) in 241 AML patients. [...]
2015 - 10.18632/oncotarget.5148
Oncotarget, Vol. 6 Núm. 31 (October 2015)  

Documents de recerca 1 registres trobats  
1.
94 p, 5.2 MB Avances en la profilaxis antifúngica primaria en la fase precoz del trasplante alogénico / Sánchez-Ortega, Isabel ; Duarte Palomino, Rafael F., dir. ; Sierra Gil, Jordi, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
En el trasplante alogénico (alo-TPH), las infecciones fúngicas invasivas (IFI) siguen teniendo un gran impacto sobre la morbi-mortalidad. La profilaxis primaria, es la única estrategia farmacológica de manejo de las infecciones fúngicas que ha demostrado disminuir la mortalidad global y la mortalidad relacionada con la IFI en el alo-TPH y en base a una revisión sistemática y metaanálisis de 64 estudios randomizados [Robenshtok E et al. [...]
Invasive fungal infections (IFI) are recognized as the leading infectious cause of mortality in allogeneic blood and marrow transplant (allo-BMT) recipients. As a general antifungal strategy, primary prophylaxis reduces all-cause mortality and IFI-related mortality in allo-BMT, and should be used for all allo-BMT recipients according to a systematic review and meta-analysis of 64 randomized controlled trials [Robenshtok E et al. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2014  

Vegeu també: autors amb noms similars
2 Duarte, R.
4 Duarte, R. F.
1 Duarte, R.F.
1 Duarte, Rafael F.
1 Duarte, Ricardo
2 Duarte, Rosa
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.